Mubadala Capital
Mubadala and QIA invests in Iambic Therapeutics $50 million funding round
Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, oversubscribed the $50 million extension to its Series B financ...
Mubadala Capital signs MoU with Woori Venture Partners
Mubadala Capital and Woori Venture Partners today announced the signing of a Memorandum of Understanding (MOU) to establish a strategic partnership. Under the MOU, the Solutions platform in Mubadala C...
Latest round of funding raises Andalusia Labs valuation to over $1 billion
Andalusia Labs, formerly known as RiskHarbor, the global leader in risk management infrastructure for digital assets, has successfully raised $48 million in Series A funding round, positioning the com...
Bayzat raises $25 million in Series C Round led by DisruptAD
Bayzat, the region’s leading employee benefits platform, has successfully closed a Series C funding round, raising $25 million. The funding round was led by DisruptAD, ADQ’s venture platform, alongsid...